...
首页> 外文期刊>Circulation journal >Balloon coronary angioplasty and long-term survival of non-diabetic patients with isolated severe left anterior descending coronary artery disease.
【24h】

Balloon coronary angioplasty and long-term survival of non-diabetic patients with isolated severe left anterior descending coronary artery disease.

机译:非糖尿病合并严重左前降支冠状动脉疾病的非糖尿病患者的球囊冠状动脉成形术和长期生存。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Although long-term survival of diabetic patients with multivessel coronary disease has been reported to be better in those treated with bypass surgery than with coronary angioplasty, it is unclear if diabetic patients who undergo coronary angioplasty show better long-term survival than those treated medically. Between 1985 and 1994, 667 consecutive patients with isolated severe (> or = 90% diameter stenosis) proximal left anterior descending (LAD) coronary artery disease were divided into 4 groups according to the initial therapeutic choice and their diabetic status: of 225 diabetic patients, 104 were treated medically and 121 underwent coronary angioplasty; of 442 non-diabetic patients, 215 were treated medically and 227 underwent coronary angioplasty. The primary end-point of follow-up was death from any cause, and the secondary end-point was cardiac death. Cox's proportional hazard model was used to assess the relative risk of baseline variables. The mean follow-up interval was 6.5+/-3.0 years. The relative distribution of baseline parameters of medically treated patients to those treated with coronary angioplasty was identical in diabetic and non-diabetic patients. Although non-diabetic patients who underwent coronary angioplasty showed better long-term survival than those treated medically, this survival advantage was not observed in diabetic patients. After adjustment of parameters using Cox's proportional hazard model, age over 65 years, coronary angioplasty and low left ventricular ejection fraction were independent determinants of total death. Long-term survival in non-diabetic patients with severe LAD coronary artery disease is more favorable in patients treated with coronary angioplasty than those treated medically, but this advantage is overridden when the patients are diabetic.
机译:尽管有报道称,在多支冠状动脉疾病的糖尿病患者中,接受搭桥手术的患者的长期生存要比冠状动脉成形术更好,但尚不清楚接受冠状动脉成形术的糖尿病患者是否表现出比药物治疗更好的长期生存。在1985年至1994年之间,根据最初的治疗选择和糖尿病状况,将667例患有严重重度(>或= 90%直径狭窄)近端左前降支(LAD)冠状动脉疾病的连续患者分为4组:225名糖尿病患者,对104例患者进行了药物治疗,其中121例进行了冠状动脉成形术;在442名非糖尿病患者中,有215名接受了药物治疗,其中227名接受了冠状动脉成形术。随访的主要终点是任何原因的死亡,次要终点是心脏性死亡。使用Cox比例风险模型评估基线变量的相对风险。平均随访时间为6.5 +/- 3.0年。在糖尿病和非糖尿病患者中,药物治疗患者的基线参数与冠状动脉成形术患者的基线参数的相对分布相同。尽管接受冠状动脉成形术的非糖尿病患者显示出比药物治疗更好的长期生存,但在糖尿病患者中未观察到这种生存优势。使用Cox比例风险模型调整参数后,年龄超过65岁,冠状动脉成形术和左心室射血分数低是总死亡的独立决定因素。患有严重LAD冠状动脉疾病的非糖尿病患者的长期存活率比接受药物治疗的患者更有利,但是当患者为糖尿病患者时,这一优势被忽略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号